Novorapid and Abdominal wall haematoma - a phase IV clinical study of FDA data
Abdominal wall haematoma is reported only by a few people who take Novorapid.
The phase IV clinical study analyzes which people take Novorapid and have Abdominal wall haematoma. It is created by eHealthMe based on reports of 19,864 people who have side effects while taking Novorapid from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
19,864 people reported to have side effects when taking Novorapid.
Among them, 5 people (0.03%) have Abdominal wall haematoma.
What is Novorapid?
Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 19,994 Novorapid users for its effectiveness, alternative drugs and more.
What is Abdominal wall haematoma?
Abdominal wall haematoma (abdominal wall blood clotting) is found to be associated with 813 drugs and 465 conditions by eHealthMe.
Number of Novorapid and Abdominal wall haematoma reports submitted per year:
Gender of people who have Abdominal wall haematoma when taking Novorapid *:
- female: 100 %
- male: 0.0 %
Age of people who have Abdominal wall haematoma when taking Novorapid *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Novorapid *:
- Lasix: 3 people, 60.00%
- Rocaltrol: 2 people, 40.00%
- Omeprazole: 2 people, 40.00%
- Levemir: 2 people, 40.00%
- Hydrocortisone: 2 people, 40.00%
- Crestor: 2 people, 40.00%
- Arixtra: 2 people, 40.00%
- Paroxetine: 1 person, 20.00%
Common side effects people have besides Abdominal wall haematoma *:
- Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 40.00%
- Overdose: 2 people, 40.00%
- Muscle Haemorrhage (bleeding in muscle): 2 people, 40.00%
- Inflammation: 2 people, 40.00%
- Haemorrhagic Anaemia (anaemia due to excessive bleeding): 2 people, 40.00%
- Anaemia (lack of blood): 2 people, 40.00%
- Shock Haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding): 1 person, 20.00%
- Haematoma (collection of blood outside the blood vessels): 1 person, 20.00%
Common conditions people have *:
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 80.00%
- Pain: 2 people, 40.00%
- Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 2 people, 40.00%
- Thrombophlebitis Superficial (swelling (inflammation) of a superficial vein caused by a blood clot): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Novorapid and have Abdominal wall haematoma?Check whether Abdominal wall haematoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Novorapid:
- Novorapid (19,994 reports)
Abdominal wall haematoma treatments and more:
- Abdominal wall haematoma (1,888 reports)
COVID vaccines that are related to Abdominal wall haematoma:
- Abdominal wall haematoma in Moderna COVID Vaccine
- Abdominal wall haematoma in Pfizer BioNTech Covid Vaccine
- Abdominal wall haematoma in Johnson and Johnson Covid Vaccine
How severe was Abdominal wall haematoma and when was it recovered:
Expand to all the drugs that have ingredients of insulin aspart recombinant:
Common drugs associated with Abdominal wall haematoma:
- Acetylsalicylic acid: 119 reports
- Aspirin: 239 reports
- Furosemide: 111 reports
- Heparin: 149 reports
- Lasix: 108 reports
- Lovenox: 141 reports
- Xarelto: 367 reports
All the drugs that are associated with Abdominal wall haematoma:
- Abdominal wall haematoma (813 drugs)
Common conditions associated with Abdominal wall haematoma:
All the conditions that are associated with Abdominal wall haematoma:
- Abdominal wall haematoma (465 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novorapid) and Novorapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.